Literature DB >> 31423529

An Early Developmental Marker of Deficit versus Nondeficit Schizophrenia.

Brian Kirkpatrick1, Özlem Gürbüz Oflezer2, Mehtap Delice Arslan3, Gary Hack4, Emilio Fernandez-Egea5,6,7.   

Abstract

People with schizophrenia and primary negative symptoms (deficit schizophrenia) differ from those without such symptoms (nondeficit schizophrenia) on risk factors, course of illness, other signs and symptoms, treatment response, and biological correlates. These differences suggest that the 2 groups may also have developmental differences. A previous study found that people with schizophrenia have a wider palate than comparison subjects. We tested the hypothesis that those with deficit and nondeficit schizophrenia would differ on palate width. A dentist made blinded measurements of palate shape in deficit (N = 21) and nondeficit (N = 25) patients and control subjects (N = 127), matched for age and gender. The deficit group had significantly wider palates than either nondeficit or control subjects (respective means [standard deviation] 37.5 [3.9], 33.7 [3.1], and 34.0 [2.9]; P < .001 for both deficit/nondeficit and deficit/control comparisons, respective effect sizes 1.08 and 1.01). The nondeficit/control difference in width was not significant (P = .83), and there were no significant group differences in length or depth. The power to detect a nondeficit/control difference in width equal in size to that of the deficit/control difference in width (3.5 mm) was 0.99 and 0.92 for a 2.0-mm difference. This difference in palate width may reflect a divergence in development between deficit and nondeficit patients that occurs by the early second trimester and is consistent with the hypothesis that deficit schizophrenia is a separate disease within the syndrome of schizophrenia.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  MESH term); cytomegalovirus; delayed effects; negative symptoms; palate; pregnancy; prenatal exposure

Mesh:

Year:  2019        PMID: 31423529      PMCID: PMC6811833          DOI: 10.1093/schbul/sbz024

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  36 in total

1.  Obstetric complications and schizophrenia: historical and meta-analytic review.

Authors:  Mary Cannon; Peter B Jones; Robin M Murray
Journal:  Am J Psychiatry       Date:  2002-07       Impact factor: 18.112

Review 2.  Minor physical anomalies: potentially informative vestiges of fetal developmental disruptions in schizophrenia.

Authors:  Michael T Compton; Raymond C K Chan; Elaine F Walker; Peter F Buckley
Journal:  Int J Dev Neurosci       Date:  2010-10-23       Impact factor: 2.457

3.  Persistent infection with neurotropic herpes viruses and cognitive impairment.

Authors:  A M M Watson; K M Prasad; L Klei; J A Wood; R H Yolken; R C Gur; L D Bradford; M E Calkins; J Richard; N Edwards; R M Savage; T B Allen; J Kwentus; J P McEvoy; A B Santos; H W Wiener; R C P Go; R T Perry; H A Nasrallah; R E Gur; B Devlin; V L Nimgaonkar
Journal:  Psychol Med       Date:  2012-09-14       Impact factor: 7.723

4.  Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample.

Authors:  Robert H Yolken; E Fuller Torrey; Jeffrey A Lieberman; Shuojia Yang; Faith B Dickerson
Journal:  Schizophr Res       Date:  2011-02-24       Impact factor: 4.939

5.  The Schedule for the Deficit syndrome: an instrument for research in schizophrenia.

Authors:  B Kirkpatrick; R W Buchanan; P D McKenney; L D Alphs; W T Carpenter
Journal:  Psychiatry Res       Date:  1989-11       Impact factor: 3.222

6.  Deficit schizophrenia: association with serum antibodies to cytomegalovirus.

Authors:  Faith Dickerson; Brian Kirkpatrick; John Boronow; Cassie Stallings; Andrea Origoni; Robert Yolken
Journal:  Schizophr Bull       Date:  2005-09-15       Impact factor: 9.306

7.  Palate and dentition in schizophrenia.

Authors:  Brian Kirkpatrick; Gary D Hack; Erik Higginbottom; Daniel Hoffacker; Emilio Fernandez-Egea
Journal:  Schizophr Res       Date:  2007-02-21       Impact factor: 4.939

8.  Seropositivity of neurotropic infectious agents in first-episode schizophrenia patients and the relationship with positive and negative symptoms.

Authors:  Abdullah Bolu; Taner Oznur; Duran Tok; Adem Balikci; Kenan Sener; Cemil Celik; Murat Gulsun
Journal:  Psychiatr Danub       Date:  2016-06       Impact factor: 1.063

9.  Palate size and shape in schizophrenia.

Authors:  Mehtap Delice; Ozlem Gurbuz; Ceyhan Oflezer; Erhan Kurt; Gamze Mandali
Journal:  Psychiatry Res       Date:  2016-07-16       Impact factor: 3.222

Review 10.  A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia.

Authors:  Sandra L Matheson; Alana M Shepherd; Kristin R Laurens; Vaughan J Carr
Journal:  Schizophr Res       Date:  2011-10-13       Impact factor: 4.939

View more
  2 in total

1.  Development and validation of a web-based prediction tool on minor physical anomalies for schizophrenia.

Authors:  Xin-Yu Wang; Jin-Jia Lin; Ming-Kun Lu; Fong-Lin Jang; Huai-Hsuan Tseng; Po-See Chen; Po-Fan Chen; Wei-Hung Chang; Chih-Chun Huang; Ke-Ming Lu; Hung-Pin Tan; Sheng-Hsiang Lin
Journal:  Schizophrenia (Heidelb)       Date:  2022-02-24

2.  Improved Multiclassification of Schizophrenia Based on Xgboost and Information Fusion for Small Datasets.

Authors:  Wenjing Zhu; Shoufeng Shen; Zhijun Zhang
Journal:  Comput Math Methods Med       Date:  2022-07-19       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.